Cargando…
Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer
Although EGFR tyrosine kinase inhibitors (TKIs) have demonstrated good efficacy in non-small-cell lung cancer (NSCLC) patients harboring EGFR mutations, most patients develop intrinsic and acquired resistance. We quantitatively profiled the phosphoproteome and proteome of drug-sensitive and drug-res...
Autores principales: | Wang, Yi-Ting, Pan, Szu-Hua, Tsai, Chia-Feng, Kuo, Ting-Chun, Hsu, Yuan-Ling, Yen, Hsin-Yung, Choong, Wai-Kok, Wu, Hsin-Yi, Liao, Yen-Chen, Hong, Tse-Ming, Sung, Ting-Yi, Yang, Pan-Chyr, Chen, Yu-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349541/ https://www.ncbi.nlm.nih.gov/pubmed/28290473 http://dx.doi.org/10.1038/srep44021 |
Ejemplares similares
-
Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer
por: Chang, Hsin-Yi, et al.
Publicado: (2017) -
Global Screening of CK2 Kinase Substrates by an Integrated Phosphoproteomics Workflow
por: Bian, Yangyang, et al.
Publicado: (2013) -
A data-independent acquisition-based global phosphoproteomics system enables deep profiling
por: Kitata, Reta Birhanu, et al.
Publicado: (2021) -
Revisional sleeve gastrectomy after failed gastric clipping for obesity: Report of two cases and review of literature
por: Yen, Chun, et al.
Publicado: (2022) -
Phosphoproteomics Identifies Oncogenic Ras Signaling Targets and Their Involvement in Lung Adenocarcinomas
por: Sudhir, Putty-Reddy, et al.
Publicado: (2011)